Solid Tumor Clinical Trials

ReadTheTrial indexes 4 studies for Solid Tumor. The most common development stage is Phase 1 (4 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.

4 clinical trials found for Solid Tumor.

Pipeline by Phase

PhaseTrialsDistribution
Phase 1 4
100%

Trial Status Breakdown

Trials for Solid Tumor

A Phase 1 Study of ASP5834 in Participants With Locally Advanced (Unresectable) or Metastatic Solid Tumor Malignancies With KRAS Mutations or KRAS Amplifications

NCT07094204 · RECRUITING · Phase 1

A Phase 1a/1b, Open-label, Dose-escalation, and Dose-expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of IMGS-001 in Patients With Relapsed or Refractory Advanced Solid Tumors

NCT06014502 · RECRUITING · Phase 1

An Open Label, Phase 1, Treatment Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of IDE397 (MAT2A Inhibitor) In Adult Participants With Advanced Solid Tumors

NCT04794699 · ACTIVE NOT RECRUITING · Phase 1

A Phase 1, Multicenter, Single Agent Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Evidence of Antitumor Activity of CPO-100 in Adult Patients With Advanced Solid Tumors

NCT04931823 · TERMINATED · Phase 1

Frequently Asked Questions

What clinical trials are available for Solid Tumor?

There are 4 clinical trials listed for Solid Tumor. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.

How do I find recruiting Solid Tumor trials?

Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.

What phases are Solid Tumor trials in?

Current Solid Tumor trials are distributed across: Phase 1 (4).

Find More Trials